BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30668751)

  • 21. Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.
    Naik RP; Derebail VK; Grams ME; Franceschini N; Auer PL; Peloso GM; Young BA; Lettre G; Peralta CA; Katz R; Hyacinth HI; Quarells RC; Grove ML; Bick AG; Fontanillas P; Rich SS; Smith JD; Boerwinkle E; Rosamond WD; Ito K; Lanzkron S; Coresh J; Correa A; Sarto GE; Key NS; Jacobs DR; Kathiresan S; Bibbins-Domingo K; Kshirsagar AV; Wilson JG; Reiner AP
    JAMA; 2014 Nov; 312(20):2115-25. PubMed ID: 25393378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of Beverages Consumed and Risk of Incident Kidney Disease.
    Rebholz CM; Young BA; Katz R; Tucker KL; Carithers TC; Norwood AF; Correa A
    Clin J Am Soc Nephrol; 2019 Jan; 14(1):49-56. PubMed ID: 30591520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study.
    Schneider AL; Lutsey PL; Selvin E; Mosley TH; Sharrett AR; Carson KA; Post WS; Pankow JS; Folsom AR; Gottesman RF; Michos ED
    Eur J Neurol; 2015 Aug; 22(8):1220-7. PubMed ID: 25962507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.
    Shroff R; Aitkenhead H; Costa N; Trivelli A; Litwin M; Picca S; Anarat A; Sallay P; Ozaltin F; Zurowska A; Jankauskiene A; Montini G; Charbit M; Schaefer F; Wühl E;
    J Am Soc Nephrol; 2016 Jan; 27(1):314-22. PubMed ID: 26069294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined associations of 25-hydroxivitamin D and parathyroid hormone with diabetes risk and associated comorbidities among U.S. white and black women.
    Xia J; Tu W; Manson JE; Nan H; Shadyab AH; Bea JW; Gower EW; Qi L; Cheng TD; Song Y
    Nutr Diabetes; 2021 Sep; 11(1):29. PubMed ID: 34531372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors for Incident CKD in Black and White Americans: The REGARDS Study.
    Cheung KL; Crews DC; Cushman M; Yuan Y; Wilkinson K; Long DL; Judd SE; Shlipak MG; Ix JH; Bullen AL; Warnock DG; Gutiérrez OM
    Am J Kidney Dis; 2023 Jul; 82(1):11-21.e1. PubMed ID: 36621640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Periodontal Disease and Kidney Function Decline in African Americans: The Jackson Heart Study.
    Grubbs V; Vittinghoff E; Beck JD; Kshirsagar AV; Wang W; Griswold ME; Powe NR; Correa A; Young B
    J Periodontol; 2015 Oct; 86(10):1126-32. PubMed ID: 26110451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation.
    Alzaman NS; Dawson-Hughes B; Nelson J; D'Alessio D; Pittas AG
    Am J Clin Nutr; 2016 Jul; 104(1):205-14. PubMed ID: 27194308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.
    Drew DA; Katz R; Kritchevsky S; Ix JH; Shlipak MG; Newman AB; Hoofnagle A; Fried L; Sarnak MJ; Gutierrez OM
    Am J Nephrol; 2018; 47(4):242-250. PubMed ID: 29621752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein Intake and Long-term Change in Glomerular Filtration Rate in the Jackson Heart Study.
    Malhotra R; Lipworth L; Cavanaugh KL; Young BA; Tucker KL; Carithers TC; Taylor HA; Correa A; Kabagambe EK; Ikizler TA
    J Ren Nutr; 2018 Jul; 28(4):245-250. PubMed ID: 29452887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
    Powe CE; Evans MK; Wenger J; Zonderman AB; Berg AH; Nalls M; Tamez H; Zhang D; Bhan I; Karumanchi SA; Powe NR; Thadhani R
    N Engl J Med; 2013 Nov; 369(21):1991-2000. PubMed ID: 24256378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of some medications given to CKD patients on vitamin D levels.
    Yuste C; Quiroga B; de Vinuesa SG; Goicoechea MA; Barraca D; Verdalles U; Luño J
    Nefrologia; 2015; 35(2):150-6. PubMed ID: 26300508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD.
    Navaneethan SD; Schold JD; Arrigain S; Jolly SE; Jain A; Schreiber MJ; Simon JF; Srinivas TR; Nally JV
    Am J Kidney Dis; 2011 Oct; 58(4):536-43. PubMed ID: 21816525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study.
    Damasiewicz MJ; Magliano DJ; Daly RM; Gagnon C; Lu ZX; Ebeling PR; Chadban SJ; Atkins RC; Kerr PG; Shaw JE; Polkinghorne KR
    BMC Nephrol; 2012 Jul; 13():55. PubMed ID: 22759247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arterial stiffness and 25-hydroxyvitamin D levels in chronic kidney disease patients.
    Akdam H; Alp A
    Rev Assoc Med Bras (1992); 2017 Oct; 63(10):910-916. PubMed ID: 29267494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D Associations With Renal, Bone, and Cardiovascular Phenotypes: African American-Diabetes Heart Study.
    Freedman BI; Divers J; Russell GB; Palmer ND; Wagenknecht LE; Smith SC; Xu J; Carr JJ; Bowden DW; Register TC
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3693-701. PubMed ID: 26196951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors for Rapid Kidney Function Decline Among African Americans: The Jackson Heart Study (JHS).
    Young BA; Katz R; Boulware LE; Kestenbaum B; de Boer IH; Wang W; Fülöp T; Bansal N; Robinson-Cohen C; Griswold M; Powe NR; Himmelfarb J; Correa A
    Am J Kidney Dis; 2016 Aug; 68(2):229-239. PubMed ID: 27066930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.
    Fox ER; Benjamin EJ; Sarpong DF; Nagarajarao H; Taylor JK; Steffes MW; Salahudeen AK; Flessner MF; Akylbekova EL; Fox CS; Garrison RJ; Taylor HA
    BMC Nephrol; 2010 Jan; 11():1. PubMed ID: 20078870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.
    Bosworth CR; Levin G; Robinson-Cohen C; Hoofnagle AN; Ruzinski J; Young B; Schwartz SM; Himmelfarb J; Kestenbaum B; de Boer IH
    Kidney Int; 2012 Sep; 82(6):693-700. PubMed ID: 22648296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart Study.
    Bansal N; Katz R; Himmelfarb J; Afkarian M; Kestenbaum B; de Boer IH; Young B
    Nephrol Dial Transplant; 2016 Dec; 31(12):2057-2064. PubMed ID: 27257276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.